These Stocks Moved the Most Today: Nvidia, Tesla, Boeing, Autodesk, Gilead, Signet, Williams-Sonoma, and More
Stocks were rising on Wednesday following the Federal Reserve’s decision to hold interest rates steady. The central bank ...
Zacks Investment Research on MSN22h
Gilead Sciences (GILD) Suffers a Larger Drop Than the General Market: Key Insights
The most recent trading session ended with Gilead Sciences (GILD) standing at $105.87, reflecting a -1.53% shift from the previouse trading day's closing. This change lagged the S&P 500's daily loss ...
S&P 500 Gains and Losses Today: Boeing Surges on Several Positive Signals
The S&P 500 added 1.1% on Wednesday, March 19, 2025, as the Fed held interest rates steady, reaffirming plans for future cuts ...
Morningstar4d
Gilead Sciences Inc GILD
We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...
Fierce Healthcare2d
HHS may cut HIV prevention efforts at the CDC. Advocates fear changes will spike infections
The Department of Health and Human Services (HHS) is reportedly poised to slash funding for domestic HIV prevention at the ...
HIV Drug Makers Get Spooked by Possible Trump Cut, but Impact Looks Manageable
Gilead Sciences has been one of the best-performing large biotech companies over the past year, rising about 50%. That is largely due to excitement over its [long-acting HIV prevention drug]( ...
Truist Financial Sticks to Its Hold Rating for Gilead Sciences (GILD)
In a report released today, Asthika Goonewardene from Truist Financial maintained a Hold rating on Gilead Sciences (GILD – Research Report).
Gilead Sciences's Options: A Look at What the Big Money is Thinking
After evaluating the trading volumes and Open Interest, it's evident that the major market movers are focusing on a price ...
Healio6d
Gilead encouraged by data on once-yearly lenacapavir for HIV prevention
New data suggest that lenacapavir delivered just once per year could be as effective for HIV prevention as the twice-yearly ...
Yahoo Finance3d
Gilead Sciences (GILD): Among the Best Biotech Stocks to Buy According to Billionaires
In this article, we are going to take a look at where Gilead Sciences, Inc. (NASDAQ:GILD) stands against other best biotech stocks. Although biotech stocks had a “challenging” year in 2024 ...
GlobalData on MSN9d
Gilead to launch Phase III once-yearly HIV PrEP trial after Phase I success
Gilead is set to launch a Phase III trial of its once-yearly lenacapavir pre-exposure prophylaxis (PrEP) for human ...
Promising Pharmaceutical Stocks To Keep An Eye On – March 19th
Eli Lilly and Company, Gilead Sciences, and D-Wave Quantum are the three Pharmaceutical stocks to watch today, according to ...